Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Primary Cytomegalovirus (CMV) infection and reactivation of persistent CMV are associated with significant morbidity and mortality in immuno‐compromised individuals. Although recovery from CMV disease is correlated with the development of CMV‐specific cytotoxic T lymphocytes (CTL), the major viral target antigens to which the response is directed are ill‐defined, though they may comprise viral structural elements. We now identify the CMV matrix protein pp65 as a significant target antigen for CD8+ class I major histocompatibility complex (MHC)‐restricted CMV‐specific CTL derived from the peripheral blood of four of five latently infected individuals. CMV‐specific CTL recognition of pp65 on target cells occurs prior to the onset of viral gene expression and persists throughout the duration of the replicative cycle. Recognition in the absence of viral gene expression suggests that abundant viral protein enters the normal trafficking pathway upon viral penetration and is readily made available to MHC molecules for presentation at the cell surface. Thus pp65 specific CTL may represent an important effector population for early control and limitation of CMV infection and disease. The observation that CMV‐specific CTL can be induced in vitro using peptide fragments derived from pp65 supports the future use and manipulation of this and similar effector populations in a clinical setting. © 1994 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
Introduction of soluble protein into the class I pathway of antigen processing and presentation
Moore, M. W., Carbone, F. R., & Bevan, M. J. (1988) · Cell · doi:10.1016/s0092-8674(88)91043-4 · Cited by 1,092
Association of class I major histocompatibility heavy and light chains induced by viral peptides
Townsend, A., Öhlén, C., Bastin, J., Ljunggren, H.-G., Foster, L., & Kärre, K. (1989) · Nature · doi:10.1038/340443a0 · Cited by 985
Cytotoxic T cells recognize fragments of the influenza nucleoprotein
Townsend, A. R. M., Gotch, F. M., & Davey, J. (1985) · Cell · doi:10.1016/0092-8674(85)90103-5 · Cited by 668
Reusser, P., Riddell, Sr., Meyers, J., & Greenberg, P. (1991) · Blood · doi:10.1182/blood.v78.5.1373.1373 · Cited by 666
Self-citationQuinnan, G. V., Kirmani, N., Rook, A. H., Manischewitz, J. F., Jackson, L., Moreschi, G., Santos, G. W., Saral, R., & Burns, W. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207013070102 · Cited by 635
In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G., & Rammensee, H.-G. (1989) · Nature · doi:10.1038/342561a0 · Cited by 631
Reddehase, M. J., Mutter, W., Münch, K., Bühring, H. J., & Koszinowski, U. H. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3102-3108.1987 · Cited by 423
Reddehase, M. J., Weiland, F., Münch, K., Jonjic, S., Lüske, A., & Koszinowski, U. H. (1985) · Journal of Virology · doi:10.1128/jvi.55.2.264-273.1985 · Cited by 403
Riddell, S. R., & Greenberg, P. D. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90210-m · Cited by 369
Self-citation
Cited by
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Self-citationSylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R., Grabstein, K. H., Hosken, N. A., Kern, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050882 · Cited by 1,339
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Self-citationWills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E., & Davis, M. M. (2000) · Nature Medicine · doi:10.1038/79526 · Cited by 672
Boeckh, M., Gooley, T., Myerson, D., Cunningham, T., Schoch, G., & Bowden, R. (1996) · Blood · doi:10.1182/blood.v88.10.4063.bloodjournal88104063 · Cited by 646
Li, C., Greenberg, P., Gilbert, M., Goodrich, J., & Riddell, Sr. (1994) · Blood · doi:10.1182/blood.v83.7.1971.1971 · Cited by 494
Self-citationMemory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time
Karrer, U., Sierro, S., Wagner, M., Oxenius, A., Hengel, H., Koszinowski, U. H., Phillips, R. E., & Klenerman, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2022 · Cited by 443
Latency and reactivation of human cytomegalovirus
Sinclair, J., & Sissons, P. (2006) · Journal of General Virology · doi:10.1099/vir.0.81891-0 · Cited by 425
Gillespie, G. M. A., Wills, M. R., Appay, V., O'Callaghan, C., Murphy, M., Smith, N., Sissons, P., Rowland-Jones, S., Bell, J. I., & Moss, P. A. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8140-8150.2000 · Cited by 420
Bunde, T., Kirchner, A., Hoffmeister, B., Habedank, D., Hetzer, R., Cherepnev, G., Proesch, S., Reinke, P., Volk, H.-D., Lehmkuhl, H., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042384 · Cited by 364
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
Rech, A. J., Mick, R., Martin, S., Recio, A., Aqui, N. A., Powell, D. J., Colligon, T. A., Trosko, J. A., Leinbach, L. I., Pletcher, C. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003330 · Cited by 337
Currier, J. R., Kuta, E. G., Turk, E., Earhart, L. B., Loomis-Price, L., Janetzki, S., Ferrari, G., Birx, D. L., & Cox, J. H. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00535-x · Cited by 320
Gilbert, M. J., Riddell, S. R., Plachter, B., & Greenberg, P. D. (1996) · Nature · doi:10.1038/383720a0 · Cited by 279
Self-citationGratama, J. W., van Esser, J. W. J., Lamers, C. H. J., Tournay, C., Löwenberg, B., Bolhuis, R. L. H., & Cornelissen, J. J. (2001) · Blood · doi:10.1182/blood.v98.5.1358 · Cited by 278
Kern, F., Surel, I. P., Faulhaber, N., Frömmel, C., Schneider-Mergener, J., Schönemann, C., Reinke, P., & Volk, H.-D. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8179-8184.1999 · Cited by 277
Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I., Pruss, A., Gratama, J., Volkmer‐Engert, R., Ewert, R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340637 · Cited by 277
Human cytomegalovirus immunity and immune evasion
Jackson, S. E., Mason, G. M., & Wills, M. R. (2011) · Virus Research · doi:10.1016/j.virusres.2010.10.031 · Cited by 262
Principles for Adoptive T Cell Therapy of Human Viral Diseases
Riddell, S. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.545 · Cited by 248
Self-citationDiamond, D. J., York, J., Sun, J.-Y., Wright, C. L., & Forman, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1751 · Cited by 248
Self-citationLaport, G. G., Levine, B. L., Stadtmauer, E. A., Schuster, S. J., Luger, S. M., Grupp, S., Bunin, N., Strobl, F. J., Cotte, J., Zheng, Z., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0095 · Cited by 179
“Median length of first complete remission, mo (range) 7 (2-34) Table 2.”
BackgroundSummary of the II International Symposium on Cytomegalovirus
de Jong, M. D., Galasso, G. J., Gazzard, B., Griffiths, P. D., Jabs, D. A., Kern, E. R., & Spector, S. A. (1998) · Antiviral Research · doi:10.1016/s0166-3542(98)00044-8 · Cited by 169
Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains
Jones, T. R., & Sun, L. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2970-2979.1997 · Cited by 165
“In HCMV-seropositive individuals, virus-specific CTLs recognize epitopes derived predominantly from pp65, a virion structural (matrix) protein (36, 38, 45).”
Background
Metadata
- Authors
- McLaughlin‐Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C., Zaia, J. A., Greenberg, P. D., & Riddell, S. R.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 1994-05
- Volume
- 43
- Issue
- 1
- Pages
- 103-110
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W2103589467
- Cited by
- 342
- References
- 22
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.